Cambridge Investment Research Advisors, Inc. First Tr ETF Vi Nasdaq Pharmac Transaction History

Cambridge Investment Research Advisors, Inc.

$36.4 Billion
Q3 2025

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in First Tr ETF Vi Nasdaq Pharmac stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 15,273 shares of FTXH stock, worth $478,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,273

Previous 16,986 10.08%

Holding current value

$478,503

Previous $435,000 0.23%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$25.77 - $28.52 $44,144 - $48,854	-1,713 Reduced 10.08%	15,273 $436,000
Q2 2025 Jul 31, 2025	BUY	$23.57 - $27.01 $9,875 - $11,317	419 Added 2.53%	16,986 $435,000
Q1 2025 Apr 22, 2025	BUY	$26.88 - $28.72 $71,581 - $76,481	2,663 Added 19.15%	16,567 $455,000
Q4 2024 Feb 14, 2025	BUY	$26.74 - $29.16 $371,792 - $405,440	13,904 New	13,904 $375,000
Q2 2023 Jul 13, 2023	SELL	$25.44 - $27.16 $207,361 - $221,381	-8,151 Reduced 34.36%	15,572 $408,000

Q1 2023 May 11, 2023	BUY	$25.25 - $28.3 $146,652 - $164,366	5,808 Added 32.42%	23,723 $619,000
Q4 2022 Feb 08, 2023	BUY	$24.01 - $28.45 $430,139 - $509,681	17,915 New	17,915 $491,000

Others Institutions Holding FTXH

# of Institutions

Shares Held

247K

Call Options Held

Put Options Held

View Full List

About FIRST TR ETF VI NASDAQ PHARMAC

Ticker FTXH
Sector ETFs
Industry ETFs

More about FTXH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. First Tr ETF Vi Nasdaq Pharmac Transaction History